نتائج البحث

A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Atypical Hemolytic Uremic Syndrome Patients

• Source: A Prospective, Non-interventional, Observational Study of Presentation, Treatment Patterns and Outcomes in Chinese Atypical Hemolytic

تفاصيل العنوان

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) (COMMUTE-a)

• Authors : Chugai Pharmaceutical

• Source: A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Adult and Adolescent Patients With

تفاصيل العنوان

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS) (COMMUTE-p)

• Authors : Chugai Pharmaceutical

• Source: A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Pediatric Patients With Atypical

تفاصيل العنوان

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy (APPELHUS)

• Source: A Multicenter, Single-arm, Open Label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult aHUS Patients Who Are Naive to Complement Inhibitor Therapy

تفاصيل العنوان

Eculizumab in Pediatric and Adult Participants With Atypical Hemolytic Uremic Syndrome (aHUS) in China (Soliris)

• Authors : AstraZeneca

• Source: Prospective, Single-Arm, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Complement Inhibitor Treatment-Naïve Pediatric and

تفاصيل العنوان

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

• Source: A Multicenter, Single Arm, Open-label Study to Evaluate Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With aHUS

تفاصيل العنوان

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

• Authors : Syneos Health

• Source: An Observational, Non-Interventional, Multi-Center, Multi-National Study of Patients With Atypical Hemolytic-

تفاصيل العنوان

What came first, atypical hemolytic uremic syndrome or malignant hypertension: a clinical dilemma.

• Authors : Sethi SK; Pediatric Nephrology, Kidney Institute, Medanta, The Medicity, Gurgaon, Haryana, India.; S S

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/diagnosis ; Hypertension, Malignant*/Hypertension, Malignant*/Hypertension, Malignant*/complications ; Hypertension, Malignant*/Hypertension, Malignant*/Hypertension, Malignant*/diagnosis

• Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (1), pp. 2327484. Date of Electronic Publication: 2024 Mar 11.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Voice of a caregiver: call for action for multidisciplinary teams in the care for children with atypical hemolytic uremic syndrome.

• Authors : Burke L; aHUS Alliance Global Action, Knutsford, UK.; Sethi SK

Subjects: Patient Care Team*/Patient Care Team*/Patient Care Team*/organization & administration ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/therapy ; Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/diagnosis

• Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Jul; Vol. 39 (7), pp. 1961-1963. Date of Electronic Publication: 2023 Oct 02.Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Atypical hemolytic-uremic syndrome after COVID-19 vaccine: A case report.

• Authors : Campos MAG; Clinical Hospital of Botucatu Medical School of São Paulo State University, Professor Mário Rubens Guimarães Montenegro Avenue, Botucatu, Brazil.; Ataídes RJC

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/diagnosis ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/immunology

• Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Jul; Vol. 12 (7), pp. e1270.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان